Stock Track | Cellebrite Soars 6.43% Pre-market on Strong Q2 Results and New CEO Appointment

Stock Track
2025/08/14

Cellebrite (CLBT) stock surged 6.43% in pre-market trading on Thursday following the release of its impressive second-quarter 2025 financial results and the announcement of a new CEO. The digital intelligence solutions provider demonstrated robust growth across key financial metrics, surpassing analyst expectations in several areas.

The company reported Q2 revenue of $113.276 million, exceeding the IBES estimate of $112.2 million. This represents an 18% year-over-year increase. Notably, Cellebrite's subscription revenue saw a significant 21% rise to $103.0 million, while its Annual Recurring Revenue (ARR) grew by 21% to $418.9 million. The adjusted EBITDA came in at $27.885 million, also surpassing the IBES estimate of $27 million, with an impressive margin of 24.6%.

Adding to the positive news, Cellebrite announced the appointment of Thomas E. Hogan as its new CEO. Hogan expressed confidence in the company's growth trajectory and its ability to support customers in law enforcement, defense, and intelligence sectors. The combination of strong financial performance and new leadership seems to have bolstered investor confidence, driving the stock's pre-market rally.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10